Background
Muscle atrophy and functional decline are well recognized in critically ill patients in the intensive care unit. However, little is known about these changes in elderly patients admitted to high care units (HCUs), who are generally less severely ill.
Methods
We conducted a prospective observational study i...
Ai Nakaguchi, A. Kawamura, Ayaka Shino et al.· Acute and Critical Care· 0 citations
Urinary titin N-fragment normalized to urinary creatinine (U-titin) is a proposed biomarker of skeletal muscle degradation and has been linked to frailty/sarcopenia. However, evidence for its prognostic utility in heart failure (HF) remains limited.
To investigate whether U-titin predicts 1-year clinical o...
T. Nishikawa, N. Nakanishi, K. Osawa et al.· European Heart Journal· 0 citations
Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are a cornerstone of contemporary heart failure (HF) therapy and provide consistent prognostic benefit, including in older, frail, and underweight patients. However, whether SGLT2i adversely affect skeletal muscle through accelerated muscle degradation remains in...
T. Nishikawa, N. Nakanishi, K. Osawa et al.· European Heart Journal· 0 citations
U-titin levels increased during empagliflozin treatment, suggesting a possible association with skeletal muscle degradation, and seem to reflect nutritional and functional status in patients with heart failure.
T. Nishikawa, N. Nakanishi, K. Osawa et al.· BMC Cardiovascular Disorders· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.